Design, Synthesis, and Antihepatitis B Virus Activities of Novel 2-Pyridone Derivatives
摘要:
A series of novel 2-pyridone derivatives were synthesized and evaluated for their antihepatitis B virus (HBV) activity and cytotoxicity in vitro. Moderate to good activity against HBV DNA replication was observed in these 2-pyridone analogues. The most active compounds were 5d and 61, with good inhibitory activity against HBV DNA replication (IC50 = 0.206 and 0.12 mu M, respectively) and remarkable high selectivity (selectivity indexes of >532 and 467, respectively). A pharmacophore model of the synthesized compounds was proposed by the GASP program. The pharmacophore model consists of three hydrophobic points, four HBA points, and one HBD point. The 2-pyridone derivatives represent a novel class of HBV inhibitors, which are worth further optimization.
Synthesis and anti-HBV activity of novel 5-substituted pyridin-2(1H)-one derivatives
作者:Yi Kai Zhang、Zhi Liang Lv、Chun Juan Niu、Ke Li
DOI:10.1016/j.cclet.2009.10.010
日期:2010.3
Abstract Four novel 5-substituted pyridine-2(1H)-onederivatives were designed and synthesized by using addition–elimination reactions. The structures of these novelly synthesized compounds were verified by 1 H NMR, ESI-MS and single crystal X-ray diffraction. Furthermore, all four compounds (most notably compound 7a ) were found to be highly efficient against hepatitis B virus (HBV) in cultured HepG2
摘要设计了四种新的5-取代吡啶-2(1H)-one衍生物,并通过加成-消除反应合成。这些新颖合成的化合物的结构通过1 H NMR,ESI-MS和单晶X射线衍射验证。此外,发现所有四种化合物(最显着的化合物7a)在培养的HepG2 2.2.15细胞中对乙型肝炎病毒(HBV)都非常有效,这使其成为抗乙型肝炎潜在生物活性分子的有希望的候选药物。
Design, Synthesis, and Antihepatitis B Virus Activities of Novel 2-Pyridone Derivatives
A series of novel 2-pyridone derivatives were synthesized and evaluated for their antihepatitis B virus (HBV) activity and cytotoxicity in vitro. Moderate to good activity against HBV DNA replication was observed in these 2-pyridone analogues. The most active compounds were 5d and 61, with good inhibitory activity against HBV DNA replication (IC50 = 0.206 and 0.12 mu M, respectively) and remarkable high selectivity (selectivity indexes of >532 and 467, respectively). A pharmacophore model of the synthesized compounds was proposed by the GASP program. The pharmacophore model consists of three hydrophobic points, four HBA points, and one HBD point. The 2-pyridone derivatives represent a novel class of HBV inhibitors, which are worth further optimization.